2
The information and data presented here was prepared for investors and potential investors. It includes forward-looking information on investigational products in development that are not available for sale in the United States. These include early-stage development products for which the performance characteristics have not yet been established.
Investor & Analyst Day key takeaways
Cologuard® execution: Offering significant benefits to patients
and providers through advanced screening; ramp accelerating
Management strength: Experienced team and track record of execution
Impactful pipeline: Leveraging first-of-its-kind commercial product
to increase shareholder value
Industry leader: Product development, regulatory reviews
and commercialization
Exact Sciences is committed to helping win the war on cancer through
early detection
OUR VISION
5
Top Related